Bedel Financial Consulting, Inc. - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 89 filers reported holding SPERO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bedel Financial Consulting, Inc. ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$33,000
-45.9%
3,8370.0%0.01%
-47.4%
Q4 2021$61,000
-14.1%
3,8370.0%0.02%
-20.8%
Q3 2021$71,000
+31.5%
3,8370.0%0.02%
+26.3%
Q2 2021$54,0003,8370.02%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders